These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The role of the ICOS/B7RP-1 T cell costimulatory pathway in murine experimental autoimmune uveoretinitis. Usui Y; Akiba H; Takeuchi M; Kezuka T; Takeuchi A; Hattori T; Okunuki Y; Yamazaki T; Yagita H; Usui M; Okumura K Eur J Immunol; 2006 Nov; 36(11):3071-81. PubMed ID: 17039566 [TBL] [Abstract][Full Text] [Related]
23. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis. Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657 [TBL] [Abstract][Full Text] [Related]
24. Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations. Kerr EC; Raveney BJ; Copland DA; Dick AD; Nicholson LB J Autoimmun; 2008 Dec; 31(4):354-61. PubMed ID: 18838247 [TBL] [Abstract][Full Text] [Related]
25. The conventional CD4+ T cell response to staphylococcal enterotoxin B is modified by its superantigenic activity. Wen R; Surman S; Blackman MA; Woodland DL Cell Immunol; 1997 Mar; 176(2):166-72. PubMed ID: 9073390 [TBL] [Abstract][Full Text] [Related]
26. Caffeic acid phenethyl ester lessens disease symptoms in an experimental autoimmune uveoretinitis mouse model. Choi JH; Roh KH; Oh H; Park SJ; Ha SM; Kang MS; Lee JH; Jung SY; Song H; Yang JW; Park S Exp Eye Res; 2015 May; 134():53-62. PubMed ID: 25795054 [TBL] [Abstract][Full Text] [Related]
27. Differential roles for IFN-gamma and IL-17 in experimental autoimmune uveoretinitis. Yoshimura T; Sonoda KH; Miyazaki Y; Iwakura Y; Ishibashi T; Yoshimura A; Yoshida H Int Immunol; 2008 Feb; 20(2):209-14. PubMed ID: 18156624 [TBL] [Abstract][Full Text] [Related]
28. The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment. Silver PB; Chan CC; Wiggert B; Caspi RR Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):2898-905. PubMed ID: 10549650 [TBL] [Abstract][Full Text] [Related]
29. Regulatory cells generated by testicular tolerization to retinal S-antigen: possible involvement of IL-4, IL-10, and TGF-beta in the suppression of experimental autoimmune uveoretinitis. Yotsukura J; Huang H; Singh AK; Shichi H Cell Immunol; 1997 Dec; 182(2):89-98. PubMed ID: 9514702 [TBL] [Abstract][Full Text] [Related]
30. Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation. Oh K; Byoun OJ; Ham DI; Kim YS; Lee DS Eur J Immunol; 2011 Feb; 41(2):392-402. PubMed ID: 21268009 [TBL] [Abstract][Full Text] [Related]
33. Prevention of experimental autoimmune uveoretinitis by vasoactive intestinal peptide. Keino H; Kezuka T; Takeuchi M; Yamakawa N; Hattori T; Usui M Arch Ophthalmol; 2004 Aug; 122(8):1179-84. PubMed ID: 15302659 [TBL] [Abstract][Full Text] [Related]
34. Administration of recombinant human IL-1 by Staphylococcus enterotoxin B prevents tolerance induction in vivo. Nakata Y; Matsuda K; Uzawa A; Nomura M; Akashi M; Suzuki G J Immunol; 1995 Nov; 155(9):4231-5. PubMed ID: 7594579 [TBL] [Abstract][Full Text] [Related]
35. Antigen-specific suppressor cells induced by FK506 in experimental autoimmune uveoretinitis in the rat. Kawashima H; Fujino Y; Mochizuki M Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2500-7. PubMed ID: 1702408 [TBL] [Abstract][Full Text] [Related]
36. Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity. Rizzo LV; Miller-Rivero NE; Chan CC; Wiggert B; Nussenblatt RB; Caspi RR J Clin Invest; 1994 Oct; 94(4):1668-72. PubMed ID: 7929845 [TBL] [Abstract][Full Text] [Related]
37. Dissociation between lymphocyte activation for proliferation and for the capacity to adoptively transfer uveoretinitis. Fox GM; Redmond TM; Wiggert B; Kuwabara T; Chader GJ; Gery I J Immunol; 1987 May; 138(10):3242-6. PubMed ID: 3106477 [TBL] [Abstract][Full Text] [Related]
38. Anti-inflammatory effect of retinoic acid on experimental autoimmune uveoretinitis. Keino H; Watanabe T; Sato Y; Okada AA Br J Ophthalmol; 2010 Jun; 94(6):802-7. PubMed ID: 19965837 [TBL] [Abstract][Full Text] [Related]
39. Effects of experimental ocular inflammation on ocular immune privilege. Ohta K; Wiggert B; Taylor AW; Streilein JW Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2010-8. PubMed ID: 10440255 [TBL] [Abstract][Full Text] [Related]